- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01569893
Life-Long Monitoring of Diabetes Mellitus in Veneto Region
RENEWING HEALTH - Large Scale Pilot in Veneto Region: Life-long Monitoring of Diabetes Mellitus
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Vicenza
-
Schio, Vicenza, Italy, 36015
- "De Lellis" Hospital - Diabetology-Endocrinology Department
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of type 2 Diabetes
- HbA1c > 53 mmol/mol (7.0 % according to NGSP)
- Capability to use the devices provided
- Being cognitively able to participate
- Capability of filling in questionnaires in german or greek or italian language
- Absence of severe comorbidity prevalent on diabetes with life expectancy < 12 months
Exclusion Criteria:
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
Usual care: treatment as usual
|
|
Experimental: Self-monitoring for patients with Dibetes mellitus type 2
|
Patients are equipped with a telemonitoring kit composed by a portable glucose meter and a gateway device for data transmission. The patient can monitor his blood glucose level with a frequency set by the clinician in the personalised treatment plan. Data are transmitted to a regional eHealth centre where a group of operators keeps these information under control and alert the reference clinician in case of worsening of symptoms. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Health related quality of life of the patients measured by the SF-36 version 2 questionnaire
Time Frame: At the entry point of intervention and at the end (12 months)
|
At the entry point of intervention and at the end (12 months)
|
Glycated hemoglobin (HbA1c) levels
Time Frame: At the entry point of intervention and at the end (12 months)
|
At the entry point of intervention and at the end (12 months)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of hospitalisations.
Time Frame: 12 months
|
12 months
|
Number of hospitalisations due to diabetes.
Time Frame: 12 months
|
12 months
|
Bed days of care
Time Frame: 12 months
|
12 months
|
Bed days of care due to diabetes.
Time Frame: 12 months
|
12 months
|
Number of visits with specialists
Time Frame: 12 months
|
12 months
|
Number of access to ER
Time Frame: 12 months
|
12 months
|
Mental status measured through Hospital Anxiety and Depression Scale (HADS).
Time Frame: At the entry point of intervention and at the end (12 months)
|
At the entry point of intervention and at the end (12 months)
|
Number of visits with specialists in diabetic center
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Francesco Calcaterra, MD, Local Health Authority "Alto Vicentino" of Thiene (VI)
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- G. A. 250487 - Veneto WP8Cl2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
HighTide Biopharma Pty LtdRecruitingT2DM (Type 2 Diabetes Mellitus)China
-
AstraZenecaRecruiting
-
Daewoong Pharmaceutical Co. LTD.Not yet recruitingT2DM (Type 2 Diabetes Mellitus)
Clinical Trials on Self-monitoring for patients with Dibetes mellitus
-
Landeskrankenanstalten-BetriebsgesellschaftEuropean CommissionCompletedDiabetes Mellitus Type 2Austria
-
Regione VenetoAzienda Ospedaliera Universitaria Integrata Verona; Azienda Ospedaliera di... and other collaboratorsCompleted
-
Landeskrankenanstalten-BetriebsgesellschaftEuropean CommissionCompletedPulmonary Disease, Chronic Obstructive (COPD)Austria
-
Sohag UniversityCompletedRenal Disorder Associated With Type II Diabetes MellitusEgypt
-
Duke UniversityMedtronicCompletedVentricular Fibrillation | Tachycardia, VentricularUnited States
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI); Duke UniversityActive, not recruiting
-
Northwell HealthNational Institute on Aging (NIA)Not yet recruitingType 2 DiabetesUnited States
-
Diakonhjemmet HospitalRecruiting
-
Kansas City Heart Rhythm Research FoundationRecruitingMyocarditis | PVC - Premature Ventricular ContractionUnited States
-
The University of Texas Health Science Center,...Harris Health SystemCompleted